POAS
PHAOS TECH-A (POAS)
NYSE
$0.17+$0.001 (+0.64%)
Price as of Sep 11, 2026 4:10 PM EDT
  • $2.3M
    Market Cap
  • N/A
    1-Year Change
  • Medical Devices
    Industry
Annual
Quarterly
04/30/2026
04/30/2025
Income Statement
Total Operating Revenue
132,077
-21.25%
167,707
N/A
Cost of Revenue
114,767
-12.15%
130,641
N/A
Gross Profit
17,310
-53.30%
37,066
N/A
Sales and Marketing Expense
19,659
-66.11%
58,008
N/A
Research and Development Expense
N/A
N/A
-139,720
N/A
Depreciation and Amortization Expense
160,846
-13.97%
186,963
N/A
Total Operating Expenses
114,767
-12.15%
130,641
N/A
Operating Profit
-6.2M
+17.74%
-5.3M
N/A
Interest Income
67,949
-55.08%
151,283
N/A
Interest Expense
-9,167
+8.32%
-8,463
N/A
Interest Income and Expense and Net
58,782
-58.84%
142,820
N/A
Total Nonoperating Income and Expense
58,782
-58.84%
142,820
N/A
Income before Taxes
-6.2M
+19.87%
-5.1M
N/A
Income Taxes
N/A
N/A
N/A
N/A
Extraordinary Items
102,283
N/A
N/A
N/A
Net Income
-6.2M
+19.87%
-5.1M
N/A
Net Income from Continuing Operations Applicable to Common
-6.2M
+19.87%
-5.1M
N/A
Basic EPS and Net Income
-0.49
+145.00%
-0.20
N/A
Diluted EPS and Net Income
-0.49
+145.00%
-0.20
N/A
Basic Weighted Average Shares
12.6M
-50.86%
25.7M
N/A
Diluted Weighted Average Shares
12.6M
-50.86%
25.7M
N/A
Balance Sheet
Cash and Cash Equivalents
762,234
+488.36%
129,552
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
762,234
+488.36%
129,552
N/A
Total Current Assets
6.4M
+319.98%
1.5M
N/A
Accumulated Depreciation
625,472
-8.69%
684,970
N/A
Property and Plant and Equipment and Net
139,273
-51.40%
286,558
N/A
Total Long-Term Assets
311,945
-25.44%
418,403
N/A
Total Assets
6.7M
+245.26%
1.9M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
Total Short-Term Debt
58,313
+4.85%
55,613
N/A
Total Current Liabilities
1.2M
-67.16%
3.8M
N/A
Total Long-Term Debt
20,053
-74.41%
78,366
N/A
Total Long-Term Liabilities
130,309
+28.93%
101,069
N/A
Total Liabilities
1.4M
-64.66%
3.9M
N/A
Retained Earnings
-18.3M
+50.61%
-12.2M
N/A
Total Stockholders Equity
5.3M
+370.04%
-2.0M
N/A
Total Shares Outstanding
16.4M
+55.13%
10.6M
N/A
Cash Flow
Cash from Operating Activities
-10.9M
+198.44%
-3.7M
N/A
Capital Expenditures
39,719
-83.47%
240,212
N/A
Cash from Investing Activities
468,397
+240.73%
-332,838
N/A
Dividends Paid
N/A
N/A
N/A
N/A
Cash from Financing Activities
11.0M
+508.23%
1.8M
N/A
Financials Ratio
Gross Margin
13.11%
N/A
N/A
N/A
Operating Margin
-4,706.77%
N/A
N/A
N/A
Return on Assets
-143.01%
N/A
N/A
N/A
Return on Equity
-368.99%
N/A
N/A
N/A
Revenue Growth
-21.25%
N/A
N/A
N/A
Current Ratio
5.11
N/A
N/A
N/A
Cash Ratio
0.61
N/A
N/A
N/A
Debt-to-Equity Ratio
0.01
N/A
N/A
N/A
Debt-to-Assets Ratio
0.01
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow